The Importance of Diversity in Clinical Trials with Sue Edelstein
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
The Importance of Diversity in Clinical Trials with Sue Edelstein
-
ナレーター：
-
著者：
On this episode, Johanna Ruddy, DHSc. MEd, Senior Director of Patient Advocacy at Ardelyx and gastroenterologist Dr. Andrea Shin interview Susan Edelstein, Senior VP of Clinical Research at Ardelyx. They discuss the critical role of patient diversity in clinical trials, emphasizing the impact of demographic factors on drug efficacy and the importance of including varied populations to ensure more comprehensive and effective treatments. The conversation also addresses strategies for improving recruitment and building trust with patients to achieve better healthcare outcomes.
At Ardelyx®, we are dedicated to improving the lives of patients by discovering, developing, and commercializing first-in-class medicines that advance care to patients with unmet medical need. Learn more about us at Ardelyx.com
Transparency Statement: Gut Matters: Discoveries and Innovations is produced by Believe Limited and made possible by Ardelyx®.
The following Ardelyx®-supported program is intended for informational and educational purposes only and is not intended as medical advice. Please speak with your healthcare professional before making any medical decisions.